Den europeiske union - norsk - EMA (European Medicines Agency)

roche registration gmbh - mosunetuzumab - lymfom, follikulært - antineoplastic agents, monoclonal antibodies - lunsumio as monotherapy is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (fl) who have received at least two prior systemic therapies.

Den europeiske union - norsk - EMA (European Medicines Agency)

avimedical b.v. - itraconazole - antimycotics for systemisk bruk, triazole derivater, itrakonazol - avian - for behandling av aspergillosis og candidiasis i følgesvenn fugler,.

Norge - norsk - Statens legemiddelverk

sandoz - københavn - takrolimusmonohydrat - kapsel, hard - 1 mg

Norge - norsk - Statens legemiddelverk

sandoz - københavn - takrolimusmonohydrat - kapsel, hard - 0.5 mg

Norge - norsk - Statens legemiddelverk

sandoz - københavn - takrolimusmonohydrat - kapsel, hard - 5 mg

Norge - norsk - Statens legemiddelverk

teva sweden ab - klaritromycin - tablett, filmdrasjert - 500 mg

Norge - norsk - Statens legemiddelverk

teva sweden ab - klaritromycin - tablett, filmdrasjert - 250 mg

Norge - norsk - Statens legemiddelverk

teva sweden ab - takrolimus - kapsel, hard - 5 mg

Den europeiske union - norsk - EMA (European Medicines Agency)

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - andre antineoplastiske midler - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

Norge - norsk - Statens legemiddelverk

accord healthcare b.v. - klaritromycin - tablett, filmdrasjert - 500 mg